Gilead ' s Trodelvy Fails to Meet Main Goal in Lung Cancer Trial Gilead ' s Trodelvy Fails to Meet Main Goal in Lung Cancer Trial

Gilead Sciences said on Monday its drug, Trodelvy, failed to significantly improve survival for previously treated patients with advanced non-small cell lung cancer (NSCLC)...Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news